Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Page 1
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.
Sci Adv. 2023 Nov 24;9(47):eadk1853. doi: 10.1126/sciadv.adk1853. Epub 2023 Nov 24.
Sci Adv. 2023.
PMID: 38000024
Free PMC article.
Correction to: Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression.
[No authors listed]
[No authors listed]
Immunother Adv. 2023 Oct 12;3(1):ltad019. doi: 10.1093/immadv/ltad019. eCollection 2023.
Immunother Adv. 2023.
PMID: 37841367
Free PMC article.
Item in Clipboard
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression.
Walsh MJ, Ali LR, Lenehan P, Kureshi CT, Kureshi R, Dougan M, Knipe DM, Dougan SK.
Walsh MJ, et al.
Immunother Adv. 2023 Jul 3;3(1):ltad011. doi: 10.1093/immadv/ltad011. eCollection 2023.
Immunother Adv. 2023.
PMID: 37461742
Free PMC article.
Item in Clipboard
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
Badran YR, Zou F, Durbin SM, Dutra BE, Abu-Sbeih H, Thomas AS, Altan M, Thompson JA, Qiao W, Leet DE, Lai PY, Horick NK, Postow MA, Faleck DM, Wang Y, Dougan M.
Badran YR, et al.
J Immunother Cancer. 2023 Jun;11(6):e007195. doi: 10.1136/jitc-2023-007195.
J Immunother Cancer. 2023.
PMID: 37349130
Free PMC article.
Item in Clipboard
Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.
Krasnow NA, Chute DF, Falade AS, North CM, Reynolds KL, Dougan ML.
Krasnow NA, et al.
Immunotherapy. 2023 Aug;15(12):913-920. doi: 10.2217/imt-2022-0245. Epub 2023 Jun 9.
Immunotherapy. 2023.
PMID: 37292001
Item in Clipboard
Immune mechanisms of toxicity from checkpoint inhibitors.
Wang SJ, Dougan SK, Dougan M.
Wang SJ, et al.
Trends Cancer. 2023 Jul;9(7):543-553. doi: 10.1016/j.trecan.2023.04.002. Epub 2023 Apr 27.
Trends Cancer. 2023.
PMID: 37117135
Free article.
Review.
Item in Clipboard
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer.
Ali LR, Garrido-Castro AC, Lenehan PJ, Bollenrucher N, Stump CT, Dougan M, Goel S, Shapiro GI, Tolaney SM, Dougan SK.
Ali LR, et al.
J Exp Med. 2023 Apr 3;220(4):e20220729. doi: 10.1084/jem.20220729. Epub 2023 Jan 23.
J Exp Med. 2023.
PMID: 36688919
Free PMC article.
Item in Clipboard
Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapy.
Yang X, Nishimiya D, Löchte S, Jude KM, Borowska M, Savvides CS, Dougan M, Su L, Zhao X, Piehler J, Garcia KC.
Yang X, et al.
Nat Biotechnol. 2023 Jul;41(7):932-943. doi: 10.1038/s41587-022-01567-w. Epub 2023 Jan 2.
Nat Biotechnol. 2023.
PMID: 36593402
Free PMC article.
Item in Clipboard
Cite
Cite